ReNeuron Group plc

AIM:RENE Stock Report

Market Cap: UK£1.9m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

ReNeuron Group Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure1.7yrs
Board average tenure1.7yrs

Recent management updates

Recent updates

We Think ReNeuron Group (LON:RENE) Needs To Drive Business Growth Carefully

Jul 15
We Think ReNeuron Group (LON:RENE) Needs To Drive Business Growth Carefully

We're Keeping An Eye On ReNeuron Group's (LON:RENE) Cash Burn Rate

Jan 22
We're Keeping An Eye On ReNeuron Group's (LON:RENE) Cash Burn Rate

Companies Like ReNeuron Group (LON:RENE) Can Afford To Invest In Growth

Oct 12
Companies Like ReNeuron Group (LON:RENE) Can Afford To Invest In Growth

Will ReNeuron Group (LON:RENE) Spend Its Cash Wisely?

Jun 04
Will ReNeuron Group (LON:RENE) Spend Its Cash Wisely?

Is ReNeuron Group (LON:RENE) In A Good Position To Deliver On Growth Plans?

Jan 12
Is ReNeuron Group (LON:RENE) In A Good Position To Deliver On Growth Plans?

Here's What We Learned About The CEO Pay At ReNeuron Group plc (LON:RENE)

Nov 20
Here's What We Learned About The CEO Pay At ReNeuron Group plc (LON:RENE)

CEO

ReNeuron Group has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Iain Ross
Executive Chairman2.8yrsUK£430.00k0.70%
£ 13.5k
John Hawkins
Company Secretary2.9yrsUK£192.91k0.26%
£ 5.0k
John Sinden
Co-Founderno dataUK£221.00kno data
Suzanne Hancock
Chief Operations Officer3.8yrsno data0.074%
£ 1.4k
Randolph Corteling
Chief Scientific Officer1.7yrsno datano data
Simon Dew
Chief Business Officer1.5yrsno datano data

1.7yrs

Average Tenure

69yo

Average Age

Experienced Management: RENE's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Iain Ross
Executive Chairman2.8yrsUK£430.00k0.70%
£ 13.5k
John Hawkins
Company Secretary1.7yrsUK£192.91k0.26%
£ 5.0k
Martin Walton
Independent Non-Executive Director2.2yrsUK£50.00k0.026%
£ 506.3
Barbara Staehelin
Senior Independent Non-Executive Director2.8yrsUK£60.00k0.61%
£ 11.8k
Michael Owen
Independent Non-Executive Director8.4yrsUK£48.00k0.020%
£ 384.0
Stefano Pluchino
Chair of the Scientific Advisory Board1.7yrsno datano data
Giuseppe Battaglia
Member of Scientific Advisory Board1.1yrsno datano data
Edit Buzas
Member of Scientific Advisory Board1.1yrsno datano data
Bernd Giebel
Member of Scientific Advisory Board1.1yrsno datano data
Kenneth Witwer
Member of Scientific Advisory Board1.1yrsno datano data

1.7yrs

Average Tenure

60yo

Average Age

Experienced Board: RENE's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/05/04 12:56
End of Day Share Price 2024/02/05 00:00
Earnings2023/09/30
Annual Earnings2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ReNeuron Group plc is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David Paul St. JohnsonAllenby Capital Limited
Navid MalikCavendish Historical (Cenkos Securities)
Vadim Alexandre KhalilDaniel Stewart & Company